Evidence map›Paper›PMID 30642267›Full record

ArticleBMC family practice2019

A qualitative study of cardiovascular disease risk communication in NHS Health Check using different risk calculators: protocol for the RIsk COmmunication in NHS Health Check (RICO) study.

Christopher J Gidlow, Naomi J Ellis, Lisa Cowap, Victoria Riley, Diane Crone, Elizabeth Cottrell, Sarah Grogan, Ruth Chambers, David Clark-Carter

Abstract readClinical Trial Protocol
In one paragraph

Article in BMC family practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Awareness of cardiovascular risk among persons with type 2 diabetes: a qualitative study.International journal of qualitative studies on health and well-being · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Christopher J GidlowStaffordshire University, Brindley Building, Leek Road, Stoke-on-Trent, ST4 2DF, UK. c.gidlow@staffs.ac.uk.ORCID 0000-0003-4990-4572
Naomi J EllisStaffordshire University, Brindley Building, Leek Road, Stoke-on-Trent, ST4 2DF, UK.
Lisa CowapStaffordshire University, Brindley Building, Leek Road, Stoke-on-Trent, ST4 2DF, UK.
Victoria RileyStaffordshire University, Brindley Building, Leek Road, Stoke-on-Trent, ST4 2DF, UK.
Diane CroneCardiff Metropolitan University, Cyncoed Campus, Cyncoed Road, Cardiff, CF23 6XD, UK.
Elizabeth CottrellKeele University, Keele, Newcastle-under-Lyme, ST5 5BG, UK.
Sarah GroganManchester Metropolitan University, Manchester Campus, Bonsall Street, Manchester, M15 6GX, UK.
Ruth ChambersStoke-on-Trent Clinical Commissioning Group, Smithfield One Building, Stoke-on-Trent, ST1 4FA, UK.
David Clark-CarterStaffordshire University, The Science Centre, Leek Road, Stoke-on-Trent, ST4 2DF, UK.

Funding

Department of Health HTA/15/170/02
6 · The paper itself

Abstract

backgroundNHS Health Check is a national cardiovascular disease (CVD) risk assessment programme for 40-74 year olds in England, in which practitioners should assess and communicate CVD risk, supported by appropriate risk-management advice and goal-setting. This requires effective communication, to equip patients with knowledge and intention to act. Currently, the QRISK®2 10-year CVD risk score is most common way in which CVD risk is estimated. Newer tools, such as JBS3, allow manipulation of risk factors and can demonstrate the impact of positive actions. However, the use, and relative value, of these tools within CVD risk communication is unknown. We will explore practitioner and patient CVD risk perceptions when using QRISK®2 or JBS3, the associated advice or treatment offered by the practitioner, and patients' responses.

methodsRIsk COmmunication in NHS Health Check (RICO) is a qualitative study with quantitative process evaluation. Twelve general practices in the West Midlands of England will be randomised to one of two groups: usual practice, in which practitioners use QRISK®2 to assess and communicate CVD risk; intervention, in which practitioners use JBS3. Twenty Health Checks per practice will be video-recorded (n = 240, 120 per group), with patients stratified by age, gender and ethnicity. Post-Health Check, video-stimulated recall (VSR) interviews will be conducted with 48 patients (n = 24 per group) and all practitioners (n = 12-18), using video excerpts to enhance participant recall/reflection. Patient medical record reviews will detect health-protective actions in the first 12-weeks following a Health Check (e.g., lifestyle referrals, statin prescription). Risk communication, patient response and intentions for health-protective behaviours in each group will be explored through thematic analysis of video-recorded Health Checks (using Protection Motivation Theory as a framework) and VSR interviews. Process evaluation will include between-group comparisons of quantitatively coded Health Check content and post-Health Check patient outcomes. Finally, 10 patients with the most positive intentions or behaviours will be selected for case study analysis (using all data sources). DISCUSSION: This study will produce novel insights about the utility of QRISK®2 and JBS3 to promote patient and practitioner understanding and perception of CVD risk and associated implications for patient intentions with respect to health-protective behaviours (and underlying mechanisms). Recommendations for practice will be developed.

trial registrationISRCTN ISRCTN10443908 . Registered 7th February 2017.

Indexed as

CommunicationPhysician-Patient RelationsCardiovascular DiseasesEnglandGeneral PracticeHumansProcess Assessment, Health CareQualitative ResearchRandomized Controlled Trials as TopicRiskRisk AssessmentRisk Reduction BehaviorState MedicineCardiovascular diseaseChronic disease preventionHealth checkProtection motivation theoryRisk communication

Identifiers

PMID30642267
PMCPMC6332912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.